MISSION: To discover treatments and the cure for Hutchinson-Gilford Progeria Syndrome
and its aging-related disorders, including heart disease.
Today, over 80 children from 30 countries are enrolled in a PRF-funded drug trial. Because of your support, the children are receiving the benefits of lonafarnib: stronger hearts and longer lives.
April 24, 2018: Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria!A new study published in The Journal of the American Medical Association (JAMA) brings new hope and optimism to the Progeria community. Click here for more details.
- May 12, 2018 in Flat Rock, MI: 13th Annual Miles for Miracles 2 Mile Walk and 3 Mile Fun Run
- September 8, 2018 in Peabody, MA: 17th Annual International Race for Research 5K & 2Mile Walk (Save the Date!)
- ANY DAY in 2018 – Anywhere: HatsON for Progeria Days 2018. Join us ANY DAY that works for you!